Shares of Shoulder Innovations, Inc. (NYSE:SI – Get Free Report) have received an average recommendation of “Moderate Buy” from the six brokerages that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $19.60.
A number of analysts have commented on SI shares. Piper Sandler started coverage on Shoulder Innovations in a research report on Monday, August 25th. They set an “overweight” rating and a $18.00 price target for the company. BTIG Research reiterated a “buy” rating and set a $23.00 price objective on shares of Shoulder Innovations in a research note on Tuesday, September 9th. Zacks Research upgraded Shoulder Innovations to a “hold” rating in a research note on Tuesday, August 26th. Wall Street Zen upgraded Shoulder Innovations from a “sell” rating to a “hold” rating in a research note on Saturday, October 11th. Finally, Morgan Stanley initiated coverage on Shoulder Innovations in a research note on Monday, August 25th. They set an “overweight” rating and a $18.00 price objective for the company.
Check Out Our Latest Stock Report on SI
Insider Buying and Selling at Shoulder Innovations
Shoulder Innovations Trading Up 1.7%
Shares of SI opened at $12.50 on Wednesday. The stock’s 50-day moving average price is $13.67. Shoulder Innovations has a one year low of $11.51 and a one year high of $17.94. The firm has a market cap of $254.56 million and a PE ratio of -0.42.
Shoulder Innovations Company Profile
We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.
See Also
- Five stocks we like better than Shoulder Innovations
- 3 Ways To Invest In Coffee, Other Than Drinking It
- This AI Chip Giant Could Be the Market’s Next Big Winner
- 3 Healthcare Dividend Stocks to Buy
- Broadcom Inks OpenAI Deal: Why It’s A Huge Win for AVGO Stock
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Institutions Are Fueling CrowdStrike’s Next Leg Higher
Receive News & Ratings for Shoulder Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shoulder Innovations and related companies with MarketBeat.com's FREE daily email newsletter.